T
Thomas Chaly
Researcher at North Shore-LIJ Health System
Publications - 26
Citations - 1323
Thomas Chaly is an academic researcher from North Shore-LIJ Health System. The author has contributed to research in topics: Citalopram & Dosimetry. The author has an hindex of 18, co-authored 26 publications receiving 1241 citations. Previous affiliations of Thomas Chaly include The Feinstein Institute for Medical Research.
Papers
More filters
Journal Article
Comparative nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET.
T. Ishikawa,Vijay Dhawan,Ken Kazumata,Thomas Chaly,Francine S. Mandel,John L. Neumeyer,Claude Margouleff,Barry Babchyck,Italo Zanzi,David Eidelberg +9 more
TL;DR: Results indicate that [123I] beta CIT-FP/SPECT can provide quantitative descriptors of presynaptic dopaminergic function comparable to those obtained with [18F]FDOPA/PET.
Journal ArticleDOI
Dopamine Cell Implantation in Parkinson's Disease: Long-Term Clinical and 18F-FDOPA PET Outcomes
Yilong Ma,Chengke Tang,Thomas Chaly,Paul Greene,Robert E. Breeze,Stanley Fahn,Curt R. Freed,Vijay Dhawan,David Eidelberg +8 more
TL;DR: Clinical benefit and graft viability are sustained up to 4 y after transplantation, and the dependence of clinical (but not imaging) outcomes on subject age and sex at 1 y may not persist over the long term.
Journal Article
Dopamine Transporter Imaging with Fluorine-18-FPCIT and PET
Ken Kazumata,Vijay Dhawan,Thomas Chaly,Angelo Antonini,Claude Margouleff,Abdelfatihe Belakhlef,John L. Neumeyer,David Eidelberg +7 more
TL;DR: FPCIT/PET demonstrated age-related decline in dopamine transporter binding in normal subjects as well as significant reductions in patients with idiopathic Parkinson's disease, which correlates with the disease severity.
Journal ArticleDOI
The Functional Neuroanatomy of Geriatric Depression
Gwenn S. Smith,Elisse Kramer,Yilong Ma,Peter B. Kingsley,Vijay Dhawan,Thomas Chaly,David Eidelberg +6 more
TL;DR: PET studies of cerebral glucose metabolism have demonstrated sensitivity in evaluating the functional neuroanatomy of treatment response variability in depression, as well as in the early detection of functional changes associated with incipient cognitive decline.
Journal Article
Input functions for 6-[fluorine-18]fluorodopa quantitation in parkinsonism: comparative studies and clinical correlations.
S. Takikawa,Vijay Dhawan,Thomas Chaly,William Robeson,Robert Dahl,Italo Zanzi,Francine S. Mandel,Phoebe G. Spetsieris,David Eidelberg +8 more
TL;DR: Results suggest that KiFD may be an optimal marker of the parkinsonian disease process and KiEFD may be a useful alternative to KiFD for most clinical research applications.